Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 35.68 CNY -7.76% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qingdao NovelBeam Technology Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Accounts Payable
ÂĄ40m
CAGR 3-Years
22%
CAGR 5-Years
16%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accounts Payable
ÂĄ42.7m
CAGR 3-Years
72%
CAGR 5-Years
44%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accounts Payable
ÂĄ1.3B
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
17%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accounts Payable
ÂĄ3.9B
CAGR 3-Years
31%
CAGR 5-Years
22%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Accounts Payable
ÂĄ133.1m
CAGR 3-Years
42%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accounts Payable
ÂĄ1.6B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao NovelBeam Technology Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
56.99 CNY
Undervaluation 37%
Intrinsic Value
Price
Q

See Also

What is Qingdao NovelBeam Technology Co Ltd's Accounts Payable?
Accounts Payable
40m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Accounts Payable amounts to 40m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
16%

Over the last year, the Accounts Payable growth was -34%. The average annual Accounts Payable growth rates for Qingdao NovelBeam Technology Co Ltd have been 22% over the past three years , 16% over the past five years .

Back to Top